National Pirogov Memorial Medical University, Vinnytsya is a medical university located in Vinnytsia, Ukraine. It was founded in 1921.

During the past decade, M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" are "Ulcerative Colitis" (9 trials), "Crohn Disease" (3 trials), "Ankylosing Spondylitis" (1 trials), "Colitis, Ulcerative" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" in a lesser frequency.

Most popular intervention types in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Etrolizumab" (4 trials), "Etrasimod" (3 trials), "RPC1063" (2 trials) and "filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU" are 16 trials for "All" genders.

Currently, there are NaN active trials in "M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in M.I. Pyrogov VRCH Dept of Gastroenterology M.I. Pyrogov VNMU, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".